UTime Limited Announcing the official website change to http://wtoworld.com./

(NASDAQ:WTO),(NasdaqGM:UTME), Tel: (86) 755 86512266 7th Floor, Building 5A Shenzhen Software Industry Base, Nanshan District Shenzhen, People's Republic of China 518061 SHENZHEN, China, Sept. 11, 2025 (GLOBE NEWSWIRE) — UTime Limited (the “Company” or “Utime”) (NASDAQ: WTO), a mobile device manufacturer and technology company, today issued a statement to clarify its management and board composition […]

UTime Limited Announcing the official website change to http://wtoworld.com./

UTime Limited Announcing the official website change to http://wtoworld.com./ GlobeNewswire September 11, 2025 Tel: (86) 755 86512266 7th Floor, Building 5A Shenzhen Software Industry Base, Nanshan District Shenzhen, People's Republic of China 518061 SHENZHEN, China, Sept. 11, 2025 (GLOBE NEWSWIRE) — UTime Limited (the “Company” or “Utime”) (NASDAQ: WTO), a mobile device manufacturer and technology

Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101

Safety endpoint met, with encouraging signs of efficacy in trial with 23 patients suffering from intracerebral hemorrhage (ICH) Findings suggest BIOX-101 reduced hematoma volume and slowed perihematomal edema growth Trend to functional recovery with BIOX-101 more favorable than in SoC group Consistent anti-inflammatory biomarker responses aligned with positive clinical efficacy signals No deaths after a

Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101

Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101 GlobeNewswire September 11, 2025 Safety endpoint met, with encouraging signs of efficacy in trial with 23 patients suffering from intracerebral hemorrhage (ICH) Findings suggest BIOX-101 reduced hematoma volume and slowed perihematomal edema growth Trend to functional recovery with BIOX-101 more favorable

Sridha Store Gears Up for Major Business Site and Product Upgrade to Elevate Customer Experience

New Delhi, Sept. 11, 2025 (GLOBE NEWSWIRE) — Sridha Store, the homegrown destination for handpicked home decor and artisanal lifestyle products, is set to unveil a comprehensive upgrade of its business platform and product offerings. As part of its next growth phase, the brand is transforming its online experience and scaling its infrastructure to align

US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker

(Copenhagen:BIOPOR), September 11, 2025News Release US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker COPENHAGEN, DENMARK and BOSTON, MA, USA, September 11 – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), is pleased to announce the upcoming US News & World Report live virtual event “New Frontiers in Kidney Care” which

Sridha Store Gears Up for Major Business Site and Product Upgrade to Elevate Customer Experience

Sridha Store Gears Up for Major Business Site and Product Upgrade to Elevate Customer Experience The homegrown lifestyle brand upgrades its site and collection to meet growing demand and elevate user experience. GlobeNewswire September 11, 2025 New Delhi, Sept. 11, 2025 (GLOBE NEWSWIRE) — Sridha Store, the homegrown destination for handpicked home decor and artisanal

US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker

US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker GlobeNewswire September 11, 2025 September 11, 2025News Release US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker COPENHAGEN, DENMARK and BOSTON, MA, USA, September 11 – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), is pleased to

DentScribe Welcomes Dr. Edward Zuckerberg and Akhil Deshpande to Advisory Board

DentScribe has exciting news to share. We've added two industry heavyweights to our advisory board: renowned dental tech pioneer Dr. Edward Zuckerberg and seasoned medtech executive Akhil Deshpande. Their joining is a huge vote of confidence in our mission to reinvent dental practice with AI. https://mma.prnewswire.com/media/2770899/dentscribe___Appointment.jpg Dr. Edward Zuckerberg: “DentScribe is invaluable. It enables dental

Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine

— Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress (IHC), including three oral presentations on eptinezumab (Vypeti®) and Lu AG09222 (anti-PACAP mAb) — New data from the open-label extension of the RESOLUTION trialand the primary results of the SUNSET extension

Scroll to Top